However, a large prospective study revealed that the detection of SEPT9 methylation has low diagnostic accuracy for CRC (sensitivity, 48.2%) and advanced precancerous lesions (sensitivity, 11.2%) [24], highlighting the need for new accurate, noninvasive tests for the early detection and management of CRC. Here, SEPTIN9 is linked to colorectal carcinoma.